Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Hagen

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Annals of Hematology|September 27, 2003
A new sarcomatoid variant of multiple myeloma in a 20-year-old maleI C Gauer, V Hagen, H Merz
Methodsx|September 7, 2023
Innate colour preference in zebrafish (Danio rerio)Ethan V Hagen, Yanbo Zhang, Trevor J Hamilton
Pharmacology, Biochemistry, and Behavior|November 23, 2024
From colours to cravings: Exploring conditioned colour preference to ethanol in zebrafishEthan V Hagen, Yanbo Zhang, Trevor J Hamilton
Die Pharmazie|July 1, 1984
[The antianaphylactic effect of derivatives of 4-oxoquinazoline, 4-oxoquinazol-3-yl-benzoic acid and 4-oxoquinazol-3-yl-acetic acid in the rat]R Grupe, W Pietzsch, V Hagen, et al.
Die Pharmazie|March 1, 1988
[X-ray structural analysis of 3 crystalline modifications of 3-cyan-5-methyl-5-(pyridinyl)-1,2-dihydro-pyrid-2-one (milrinone)]G Reck, V Hagen, G Bannier, et al.
Die Pharmazie|October 1, 1992
[Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives]V Hagen, A Hagen, E G Krause, et al.
The EMBO Journal|January 7, 1999
Ca2+ permeation in cyclic nucleotide-gated channelsC Dzeja, V Hagen, U B Kaupp, et al.
Scientific Reports|February 22, 2024
Repeated microdoses of LSD do not alter anxiety or boldness in zebrafishEthan V Hagen, Melike Schalomon, Yanbo Zhang, et al.
Die Pharmazie|January 1, 1989
[Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines]V Hagen, A Hagen, S Heer, et al.
Die Pharmazie|October 1, 1992
[Potential cardiotonics. 15. Crystal modifications of 3-cyano-2-morpholino-5-(4-pyridinyl)pyridine (AWD 122-14)]V Hagen, G Reck, M Dathe, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Annals of Hematology|September 27, 2003
A new sarcomatoid variant of multiple myeloma in a 20-year-old maleI C Gauer, V Hagen, H Merz
Methodsx|September 7, 2023
Innate colour preference in zebrafish (Danio rerio)Ethan V Hagen, Yanbo Zhang, Trevor J Hamilton
Pharmacology, Biochemistry, and Behavior|November 23, 2024
From colours to cravings: Exploring conditioned colour preference to ethanol in zebrafishEthan V Hagen, Yanbo Zhang, Trevor J Hamilton
Die Pharmazie|July 1, 1984
[The antianaphylactic effect of derivatives of 4-oxoquinazoline, 4-oxoquinazol-3-yl-benzoic acid and 4-oxoquinazol-3-yl-acetic acid in the rat]R Grupe, W Pietzsch, V Hagen, et al.
Die Pharmazie|March 1, 1988
[X-ray structural analysis of 3 crystalline modifications of 3-cyan-5-methyl-5-(pyridinyl)-1,2-dihydro-pyrid-2-one (milrinone)]G Reck, V Hagen, G Bannier, et al.
Die Pharmazie|October 1, 1992
[Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives]V Hagen, A Hagen, E G Krause, et al.
The EMBO Journal|January 7, 1999
Ca2+ permeation in cyclic nucleotide-gated channelsC Dzeja, V Hagen, U B Kaupp, et al.
Scientific Reports|February 22, 2024
Repeated microdoses of LSD do not alter anxiety or boldness in zebrafishEthan V Hagen, Melike Schalomon, Yanbo Zhang, et al.
Die Pharmazie|January 1, 1989
[Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines]V Hagen, A Hagen, S Heer, et al.
Die Pharmazie|October 1, 1992
[Potential cardiotonics. 15. Crystal modifications of 3-cyano-2-morpholino-5-(4-pyridinyl)pyridine (AWD 122-14)]V Hagen, G Reck, M Dathe, et al.
Pageof 6